Kadimastem Ltd
Kadimastem Ltd (KMSTF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
kmstf · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Kadimastem Ltd (KMSTF) measures how much investors pay for each dollar of the company's trailing earnings. KMSTF's current PE ratio of N/A is calculated by dividing its stock price of $3.21 by its TTM earnings per share of -$11.88.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2012 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Kadimastem LtdYou KMSTF | $10M | N/A | — | -$11.88 |
 American Hemp Ventures, Inc. AMHV | $16M | N/A | — | — |
 Antisense Therapeutics Limited ATHJF | $20M | N/A | — | -$0.01 |
 OKYO Pharma Limited EMMLF | $23M | N/A | — | — |
 Noxopharm Limited NOXOF | $15M | N/A | — | -$0.01 |
 Organicell Regenerative Medicine, Inc. OCEL | $20M | N/A | — | -$0.86 |
 OptiBiotix Health Plc OPBXF | $20M | 6.55x | — | $0.03 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | — | $-6.32 | — | |
2023-12-31 FY2023 | — | $-4.02 | — | |
2022-12-31 FY2022 | — | $-9.23 | — | |
2021-12-31 FY2021 | — | $-119.98 | — | |
2020-12-31 FY2020 | — | $-166.72 | — | |
2019-12-31 FY2019 | — | $-262.72 | — | |
2018-12-31 FY2018 | — | $-438.05 | — | |
2017-12-31 FY2017 | — | $-632.32 | — | |
2016-12-31 FY2016 | — | $-1303.72 | — | |
2015-12-31 FY2015 | — | $-1331.67 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Kadimastem Ltd (KMSTF) measures how much investors pay for each dollar of the company's trailing earnings. KMSTF's current PE ratio of N/A is calculated by dividing its stock price of $3.21 by its TTM earnings per share of -$11.88.
Frequently asked questions
KMSTF pe ratio · 6 questionsKMSTF's current PE ratio is N/A as of 2026-06-08, based on a stock price of $3.21 and TTM EPS of -$11.88. Data sourced from Financial Modeling Prep via KMSTF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Kadimastem Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08